Compare Stocks Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities. Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare OTCMKTS:FOBIFOTCMKTS:FRXIFOTCMKTS:MXDHFOTCMKTS:WANSF On This Page Performance ChartPrice & VolumeMarketRank™Analyst RatingsSales & Book ValueProfitability & EarningsDividendsDebtOwnershipMiscellaneousHeadlinesAbout Comparison Ideas Stock Ideas Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeFOBIFFobi AI$0.00-40.0%$0.02$0.00▼$0.06$1.01M-0.589,918 shs66,933 shsFRXIFFRX Innovations$0.04$0.04$0.02▼$0.24$4.93M1.75N/AN/AMXDHFMDxHealth$0.00$0.25▼$0.35$3.90M1.461,000 shs300 shsWANSFCirata$0.96$0.25$0.00▼$1.90$120.76M-19.681,255 shsN/A The Best Nuclear Energy Stocks to BuyNuclear energy stocks are roaring. It's the hottest energy sector of the year. Cameco Corp, Paladin Energy, and BWX Technologies were all up more than 40% in 2024. The biggest market moves could still be ahead of us, and there are seven nuclear energy stocks that could rise much higher in the next several months. To unlock these tickers, enter your email address below.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceFOBIFFobi AI0.00%-62.50%-34.78%-75.00%-87.37%FRXIFFRX Innovations0.00%0.00%0.00%0.00%0.00%MXDHFMDxHealth0.00%0.00%0.00%0.00%0.00%WANSFCirata0.00%+7,801.24%+282.42%+2,043.61%-8.07%Compare MarketRank™CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & ValuationFOBIFFobi AIN/AN/AN/AN/AN/AN/AN/AN/AFRXIFFRX InnovationsN/AN/AN/AN/AN/AN/AN/AN/AMXDHFMDxHealthN/AN/AN/AN/AN/AN/AN/AN/AWANSFCirataN/AN/AN/AN/AN/AN/AN/AN/ACompare Analyst ForecastsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceFOBIFFobi AI 0.00N/AN/AN/AFRXIFFRX Innovations 0.00N/AN/AN/AMXDHFMDxHealth 0.00N/AN/AN/AWANSFCirata 0.00N/AN/AN/ACompare Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookFOBIFFobi AI$1.51M0.67N/AN/A$0.01 per share0.45FRXIFFRX Innovations$3.11M1.58N/AN/A$0.01 per share4.16MXDHFMDxHealth$37.05M0.00N/AN/A$0.60 per share0.00WANSFCirata$6.70M18.02N/AN/A$0.25 per share3.82Compare Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateFOBIFFobi AI-$9.44M-$0.04N/A∞N/AN/AN/AN/AN/AFRXIFFRX Innovations-$8.51M-$0.09N/A∞N/AN/A-434.04%-8.79%N/AMXDHFMDxHealth-$44.04MN/A0.00N/AN/AN/AN/AN/AN/AWANSFCirata-$36.48MN/A0.00N/AN/AN/AN/AN/AN/ACompare DividendsCompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive GrowthFOBIFFobi AIN/AN/AN/AN/AN/AFRXIFFRX InnovationsN/AN/AN/AN/AN/AMXDHFMDxHealthN/AN/AN/AN/AN/AWANSFCirataN/AN/AN/AN/AN/ACompare DebtCompanyDebt-to-Equity RatioCurrent RatioQuick RatioFOBIFFobi AIN/AN/AN/AFRXIFFRX InnovationsN/A0.900.90MXDHFMDxHealth1.451.251.19WANSFCirata0.012.65N/ACompare OwnershipInstitutional OwnershipCompanyInstitutional OwnershipFOBIFFobi AIN/AFRXIFFRX InnovationsN/AMXDHFMDxHealthN/AWANSFCirataN/AInsider OwnershipCompanyInsider OwnershipFOBIFFobi AIN/AFRXIFFRX InnovationsN/AMXDHFMDxHealth1.70%WANSFCirataN/ACompare Miscellaneous StatsCompanyEmployeesShares OutstandingFree FloatOptionableFOBIFFobi AI26224.60 millionN/ANot OptionableFRXIFFRX Innovations21118.46 millionN/ANot OptionableMXDHFMDxHealth25215.60 million15.33 millionNot OptionableWANSFCirata112126.31 millionN/ANot OptionableWANSF, FRXIF, FOBIF, and MXDHF HeadlinesRecent News About These Companies3 UK Penny Stocks With Market Caps Larger Than £20MMay 9, 2025 | uk.finance.yahoo.comCirata Successfully Passes All Resolutions at AGMMay 8, 2025 | tipranks.comCirata Secures $2M Data Automation Contract with Leading UK RetailerMarch 31, 2025 | tipranks.comCirata And 2 Other Prominent Penny Stocks On The UK ExchangeFebruary 14, 2025 | finance.yahoo.comCirata And 2 Other Penny Stocks On The UK Exchange To WatchJanuary 16, 2025 | finance.yahoo.comCirata plc Reports Strongest Bookings Quarter Since 2022, Sets Stage for Growth in 2025January 9, 2025 | tipranks.comCirata Secures Major Contract with Top US Bank, Withdraws FY24 Bookings GuidanceDecember 16, 2024 | tipranks.comCirata PLC (WANSF) (Q2 2024) Earnings Call Highlights: Strategic Cost Reductions and Revenue ...October 10, 2024 | finance.yahoo.comCirata, formerly WANdisco, maintains FY2024 guidance of $13-$15m – good progress ‘not represented in the headline numbers’October 9, 2024 | prolificnorth.co.ukCirata Plc (CRTA.AQ)September 20, 2024 | sg.finance.yahoo.comCirata plc (WANSF)July 20, 2024 | finance.yahoo.com“Rebuild from the ground up” as Cirata reflects on WANdisco periodApril 4, 2024 | prolificnorth.co.ukCirata plc's (LON:CRTA) largest shareholders are individual investors with 47% ownership, institutions own 17%January 22, 2024 | finance.yahoo.comWANdisco successor targets breakeven following promising Q4 resultsJanuary 15, 2024 | prolificnorth.co.ukCirata plc (WANSF) Stock Historical Prices & Data - Yahoo FinanceJanuary 11, 2024 | finance.yahoo.comCirata 'getting off the canvas' in wake of WANdisco scandal, new CEO claims as latest results publishedJanuary 9, 2024 | msn.comWANdisco plc (WANSF) stock historical prices & data – Yahoo FinanceDecember 29, 2023 | uk.finance.yahoo.comFavourable Signals For Cirata: Numerous Insiders Acquired StockDecember 12, 2023 | finance.yahoo.comCirata plc (CRTA.L)November 6, 2023 | finance.yahoo.comWANdisco rebrands as Cirata in "new start for the company"October 4, 2023 | shareprices.comMedia Sentiment Over TimeWANSF, FRXIF, FOBIF, and MXDHF Company DescriptionsFobi AI OTCMKTS:FOBIF$0.0045 0.00 (-40.00%) As of 03:05 PM EasternFobi AI Inc., together with its subsidiaries, operates as a technology and data intelligence company in North America and Europe. It provides software as a service; consulting and development services; and resells, refers, and licenses its products. The company also offers mobile wallet solutions, digital coupons, and customer insights solutions. It serves various industries, including the hospitality and tourism industries. The company was formerly known as Loop Insights Inc. Fobi AI Inc. is based in Vancouver, Canada.FRX Innovations OTCMKTS:FRXIF$0.04 0.00 (0.00%) As of 06/2/2025FRX Innovations Inc. manufactures and sells flame-retardant polyphosphate polymers in Asia, Europe, and internationally. The company's products including homopolymers used in carpets, textiles, connectors, wires and cables, transparent sheet products, and transparent blown films; Co-polymers used in housings, sheets, fibers, and lightings; and reactive oligomers used in decorative laminates, wall panels, copper clad laminates for printed circuit boards, and protective sheets and coatings. It serves building and construction, fiber, textiles, electrical, electronics, and transportation sectors. The company was formerly known as FRX Polymers Inc. and changed its name to FRX Innovations Inc. in May 2022. FRX Innovations Inc. is based in Vancouver, Canada.MDxHealth OTCMKTS:MXDHFMDxHealth SA, a commercial-stage precision diagnostics company, provides urologic solutions in the United States, Europe, and internationally. Its novel prostate cancer genomic testing solutions are SelectMDx, a non-invasive urine test; and ConfirmMDx, an epigenetic test, which provide physicians with a clinical pathway to identify clinically prostate cancer while minimizing the use of invasive procedures that are prone to complications. The company was formerly known as OncoMethylome Sciences SA and changed its name to MDxHealth SA in October 2010. MDxHealth SA was incorporated in 2003 and is headquartered in Herstal, Belgium.Cirata OTCMKTS:WANSF$0.96 0.00 (0.00%) As of 06/2/2025Cirata plc, together with its subsidiaries, engages in the development and provision of collaboration software in North America, Europe, China, and internationally. The company provides Data Migrator, an automated solution that moves on-premises HDFS data, Hive metadata, local filesystem, or cloud data sources to any cloud or on-premises environment; and Data Migrator for Hadoop, a cloud migration solution that automates the seamless transfer of HDFS data and Hive metadata to the cloud. It also offers Access Control Plus, an access control solution, that enables project administrators to manage the complexity of complete and proper authentication (AuthN) and authorization (AuthZ) configuration file generation; and Gerrit MultiSite, a development team collaboration solution, which enables replication of Gerrit server and packaged in a simple to deploy and maintain format. In addition, the company provides Git MultiSite and Subversion MultiSite Plus solutions enable distributed teams to collaborate as one with no downtime, no disruption, and consistent security policy enforcement across all locations. It offers its solutions for automotive, telecommunications, and financial service industries. The company was formerly known as WANdisco plc and changed its name to Cirata plc in October 2023. Cirata plc was incorporated in 2012 and is based in St. Helier, Jersey. More Stock Comparisions from MarketBeat Stock Comparison Ideas (A-K)5GAgricultureAirlineAmerica FirstApparelArtificial IntelligenceAutomotiveBankBiotechBitcoinBlockchainBlue ChipCanadianCannabisCasinoChatGPTChineseCloud StorageCryptocurrencyCybersecurityDefenseDividendDow 30EcommerceElectric VehiclesEnergyEntertainmenteSportsEV ChargingFertilizerGoldGroceryGrowthHealthcareHigh DividendHotelStock Comparison Ideas (L-Z)Large CapLeisureLithiumMagnificent SevenMega CapMemeMetaverseMid CapMiningMusic IndustryNanotechnologyNFTNuclear EnergyOilPharmaceuticalQuantum ComputingRenewable EnergyRestaurantRetailSemiconductorSocial MediaSolarSpaceTechnologyTelecomToyUtilityVideo GameVirtual RealityWallStreetBets More Stock Ideas from MarketBeat Stock Lists 5G Stocks Biotech Stocks Blue Chip Stocks DOW 30 Stocks FAANG Stocks Gold Stocks Large Cap Stocks Lumber Stocks Marijuana Stocks Micro Cap Stocks Oil Stocks REITs Small Cap Stocks SPACs Travel Stocks Trillion Dollar Stocks Water Stocks Warren Buffett Stocks Low Priced Stocks Penny Stock List Popular Penny Stocks Top Stocks Today Stocks on Sale Stocks Under $0.05 Stocks Under $0.10 Stocks Under $0.25 Stocks Under $0.50 Stocks Under $1 Stocks Under $2 Stocks Under $3 Stocks Under $5 Stocks Under $10 Stocks Under $20 Stocks Under $30 Stocks Under $50 Stocks By Exchange NASDAQ Stocks NYSE Stocks NYSEAMERICAN Stocks NYSEARCA Stocks NYSEMKT Stocks OTCMKTS Stocks TSX Stocks TSXV Stocks LSE Stocks BATS Stocks Latest Stock Ideas 3 Reasons Amazon Could Be the Best Tech Performer in June Ollie’s Q1 Earnings: The Good, the Bad, and What’s Next Applied Digital: CoreWeave’s AI Deal Lights a $7 Billion Fuse Qualcomm: A Technical Deep-Dive Confirms the Worst Rocket Lab Expands Into Payloads: Should You Be Paying Attention? Steel Dynamics Shares Climb After Tariff Announcement Palantir Soars on Government Deals as Valuation Debate Lingers Broadcom Earnings Preview: AVGO Stock Near Record Highs Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
